Modafinil use in patients with a primary psychiatric illness.
Black
Warwick
W
Hoey
Peter
P
Mayze
Thomas
T
D000328:Adult; D000339:Affect / Q000187:drug effects; D001143:Arousal / Q000187:drug effects*; D001559:Benzhydryl Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D020208:Brain Injury, Chronic / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D006970:Disorders of Excessive Somnolence / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D005221:Fatigue / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000523:psychology; D008875:Middle Aged; D000077408:Modafinil; D009042:Motivation; D020181:Sleep Apnea, Obstructive / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D014256:Trichotillomania / Q000188:drug therapy / Q000523:psychology; D014851:Wakefulness / Q000187:drug effects*
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D000077408:Modafinil